Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance
Top Cited Papers
- 1 July 2002
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 360 (9326), 34-40
- https://doi.org/10.1016/s0140-6736(02)09330-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Community-based approaches to HIV treatment in resource-poor settingsThe Lancet, 2001
- HIV/AIDS Treatment for MillionsScience, 2001
- Companies, Donors Pledge to Close Gap in AIDS TreatmentScience, 2000
- AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patientsAIDS, 2000
- A Randomized, Controlled Trial of Indinavir, Zidovudine, and Lamivudine in Adults with Advanced Human Immunodeficiency Virus Type 1 Infection and Prior Antiretroviral TherapyThe Journal of Infectious Diseases, 1999
- Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug ReactionsAnnals of Internal Medicine, 1999
- A Randomized, Controlled, Double-Blind Study Comparing the Survival Benefit of Four Different Reverse Transcriptase Inhibitor Therapies (Three-Drug, Two-Drug, and Alternating Drug) for the Treatment of Advanced AIDSJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected PatientsJAMA, 1998
- Antiretrovirals for developing worldThe Lancet, 1998
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986